Patents by Inventor Colene Drace

Colene Drace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

HIGH THROUGHPUT ASSAY FOR HUMAN RHO KINASE ACTIVITY WITH ENHANCED SIGNAL-TO-NOISE RATIO

Publication number: 20080096238

Abstract: The present invention provides a high throughput assay with increased signal-to-noise ration for human Rho kinase activity in vitro, and methods and kits therefor. A high throughput method of assaying a test compound for human Rho kinase modulating activity is also provided.

Type: Application

Filed: December 6, 2007

Publication date: April 24, 2008

Applicant: ALCON, INC.

Inventors: Najam Sharif, Colene Drace, Gary Williams
High throughput assay for human Rho kinase activity

Publication number: 20060115870

Abstract: The present invention provides a high throughput assay for human Rho kinase activity in vitro, and methods and kits therefor. A high throughput method of assaying a test compound for human Rho kinase modulating activity is also provided.

Type: Application

Filed: March 25, 2005

Publication date: June 1, 2006

Applicant: Alcon, Inc.

Inventors: Najam Sharif, Colene Drace, Gary Williams
Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes

Publication number: 20050137123

Abstract: The present invention provides compositions and methods for treating glaucoma, ocular hypertension, and age-related macular degeneration. More specifically, the present invention describes the use of agents that down-regulate expression of tanis and/or p21Waf1/Cip1/Sd1 genes to treat such disorders of the eye.

Type: Application

Filed: December 7, 2004

Publication date: June 23, 2005

Inventors: Colene Drace, Gary Williams, Curtis Kelly, Najam Sharif

HIGH THROUGHPUT ASSAY FOR HUMAN RHO KINASE ACTIVITY WITH ENHANCED SIGNAL-TO-NOISE RATIO

High throughput assay for human Rho kinase activity

Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes